Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...4, 5, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-16
5:10 pm
Purchase
13GAcuityAds Holdings Inc.
ATY
K2 PRINCIPAL FUND L.P.3,198,531
5.63%
350,415increase
(+12.30%)
View
2023-03-16
5:06 pm
Purchase
13GAcuityAds Holdings Inc.
ATY
K2 PRINCIPAL FUND L.P.2,848,116
5.01%
2,848,116increase
(New Position)
View
2023-02-13
4:48 pm
Purchase
13GSan Juan Basin Royalty Trust
SJT
K2 PRINCIPAL FUND L.P.2,367,933
5.08%
1,061,124increase
(+81.20%)
View
2023-02-13
4:43 pm
Sale
13GSan Juan Basin Royalty Trust
SJT
K2 PRINCIPAL FUND L.P.1,306,809
2.8%
-1,033,159decrease
(-44.15%)
View
2023-02-13
4:39 pm
Sale
13GSolid Biosciences Inc.
SLDB
K2 PRINCIPAL FUND L.P.284,871
1.46%
-5,424,329decrease
(-95.01%)
View
2023-02-13
4:32 pm
Purchase
13GARS Pharmaceuticals, Inc.
SPRY
K2 PRINCIPAL FUND L.P.2,045,348
2.2%
138,730increase
(+7.28%)
View
2023-02-08
5:51 pm
Sale
13GTCR2 Therapeutics Inc.
TCRR
K2 PRINCIPAL FUND L.P.0
0%
-1,950,628decrease
(Position Closed)
View
2023-02-08
5:22 pm
Sale
13GGoldenstone Acquisition Limited
GDST
K2 PRINCIPAL FUND L.P.0
0%
-375,000decrease
(Position Closed)
View
2023-02-08
5:21 pm
Unchanged
13GSagaliam Acquisition Corp.
SAGA
K2 PRINCIPAL FUND L.P.0
0%
0
(Unchanged)
View
2023-02-08
5:06 pm
Unchanged
13GRelativity Acquisition Corp.
RACY
K2 PRINCIPAL FUND L.P.0
0%
0
(Unchanged)
View
2023-02-07
7:00 pm
Sale
13GAVROBIO, Inc.
AVRO
K2 PRINCIPAL FUND L.P.0
0%
-2,235,868decrease
(Position Closed)
View
2022-08-31
6:13 pm
Purchase
13GTCR2 Therapeutics Inc.
TCRR
K2 PRINCIPAL FUND L.P.1,950,628
5.05%
1,950,628increase
(New Position)
View
2022-08-31
5:49 pm
Purchase
13GSolid Biosciences Inc.
SLDB
K2 PRINCIPAL FUND L.P.5,709,200
5.05%
5,709,200increase
(New Position)
View
2022-07-29
6:57 pm
Purchase
13GAVROBIO, Inc.
AVRO
K2 PRINCIPAL FUND L.P.2,235,868
5.12%
2,235,868increase
(New Position)
View
2022-07-15
6:03 pm
Purchase
13GARS Pharmaceuticals, Inc.
SPRY
K2 PRINCIPAL FUND L.P.1,906,618
5.41%
1,906,618increase
(New Position)
View
2022-03-22
5:08 pm
Purchase
13GGoldenstone Acquisition Limited
GDST
K2 PRINCIPAL FUND L.P.375,000
5.66%
375,000increase
(New Position)
View
2022-02-16
5:00 pm
Purchase
13GRelativity Acquisition Corp.
RACY
K2 PRINCIPAL FUND L.P.670,000
5.36%
670,000increase
(New Position)
View
2022-01-31
6:21 pm
Sale
13GPasithea Therapeutics Corp.
KTTA
K2 PRINCIPAL FUND L.P.1,094,418
4.99%
-605,582decrease
(-35.62%)
View
2022-01-27
6:54 pm
Sale
13GWelsbach Technology Metals Acquisition Corp.
WTMA
K2 PRINCIPAL FUND L.P.436,100
4.49%
-63,900decrease
(-12.78%)
View
2022-01-26
5:25 pm
Sale
13GIgnyte Acquisition Corp.
IGNY
K2 PRINCIPAL FUND L.P.259,958
3.57%
-152,693decrease
(-37.00%)
View
Goto 0, 1, 2, ...4, 5, Next